EPYSQLI 300 mg/30mL
Eculizumab-aagh · INJECTION, SOLUTION · Teva Pharmaceuticals USA, Inc.
EPYSQLI is a injection, solution containing eculizumab-aagh at 300 mg/30mL, taken intravenous. Manufactured by Teva Pharmaceuticals USA, Inc..
Key Facts
- Brand Name
- EPYSQLI
- Generic Name
- Eculizumab-aagh
- NDC Code (Product)
51759-208- Manufacturer
- Teva Pharmaceuticals USA, Inc.
- Strength
- 300 mg/30mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BLA761340
- Drug Class
- Complement Inhibitor [EPC]
- Marketing Start
- 04/07/2025
Recall History
No Recall HistoryFrequently Asked Questions
What is EPYSQLI used for?
EPYSQLI contains Eculizumab-aagh. It is a injection, solution taken intravenous. Consult your doctor for specific uses.
Is EPYSQLI a controlled substance?
EPYSQLI is not classified as a controlled substance by the DEA.
What is the generic name for EPYSQLI?
The generic name for EPYSQLI is Eculizumab-aagh. There are no other listed brand versions of Eculizumab-aagh.
What is the NDC code for EPYSQLI 300 mg/30mL?
The NDC (National Drug Code) for EPYSQLI 300 mg/30mL is 51759-208, listed by Teva Pharmaceuticals USA, Inc..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)